4//SEC Filing
Hollingsworth Jane H 4
Accession 0001437749-23-005435
CIK 0001053691other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:20 PM ET
Size
8.9 KB
Accession
0001437749-23-005435
Insider Transaction Report
Form 4
Hollingsworth Jane H
Director
Transactions
- Disposition to Issuer
Common Stock
2023-02-28−68→ 1,116 total - Exercise/Conversion
Common Stock
2023-02-28+183→ 1,184 total - Exercise/Conversion
Restricted Stock Unit
2023-02-28−183→ 366 total→ Common Stock (183 underlying)
Footnotes (1)
- [F1]On February 28, 2023 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 115 Shares and (ii) $391.00 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $5.75. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001297141
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:20 PM ET
- Size
- 8.9 KB